Biohaven Ltd. Common Shares (NY:BHVN)

12.87 UNCHANGED

Delayed Quote Updated: 7:00 PM EDT, Oct 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Biohaven Ltd. Common Shares

< Previous 1 2

...

9 10 11 12 13 14 15 16 Next >

Biohaven/Pfizer Partnered Rimegepant Asia-Pacific Migraine Trial Meets Primary Endpoints ↗

February 14, 2022

Biohaven Pharmaceutical Holding Company Ltd (NYSE: BHVN) and Pfizer Inc (NYSE: PFE) reported topline results from an Asia-Pacific, Phase 3 trial of...

Via Benzinga

New Psychedelics ETF Launches On NYSE Arca ↗

February 02, 2022

Elemental Advisors Inc. has launched its first ETF, composed of companies involved in research, development, production or use of psychedelics to address medical conditions. The PSYK ETF (NYSE: PSYK)...

Via Benzinga

This Tattooed, Cowboy-Boot-Wearing Top CEO Refuses To Go Clean Cut ↗

January 20, 2022

John Chiminski knows he doesn't fit the traditional image of a corporate bigwig. And the Catalent CEO is not about to change.

Via Investor's Business Daily

Where Biohaven Pharma Hldgs Stands With Analysts ↗

January 07, 2022

Analysts have provided the following ratings for Biohaven Pharma Hldgs (NYSE:BHVN...

Via Benzinga

2022 Could be a Banner Year for Biotech Stocks as per top managers (SPRC, HOTH, NLSP, PSTV, IMMX, GNPX, NRBO)

January 06, 2022

Via AB Newswire

Analyst Ratings For Biohaven Pharma Hldgs ↗

October 19, 2021

Within the last quarter, Biohaven Pharma Hldgs (NYSE:BHVN) has observed the f...

Via Benzinga

Where Biohaven Pharma Hldgs Stands With Analysts ↗

September 13, 2021

Within the last quarter, Biohaven Pharma Hldgs (NYSE:BHVN) has observed the ...

Via Benzinga

The Daily Biotech Pulse: Lilly Strikes Neurological R&D Collaboration, Valneva Confirms Vaccine Timelines, Biohaven Gains On Strong Migraine Drug Sales ↗

January 06, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Illumina Announces Co-Development Partnership With SomaScan For Accelerating...

Via Benzinga

Biohaven's Zavegepant Pain Spray Aces Late-Stage Migraine Trial ↗

December 06, 2021

Biohaven Pharmaceutical Holding Company Ltd (NYSE: BHVN) is eyeing filing for approval in early 2022 for its experimental pain spray after new data showed it hit its...

Via Benzinga

What 6 Analyst Ratings Have To Say About Biohaven Pharma Hldgs ↗

November 10, 2021

Within the last quarter, Biohaven Pharma Hldgs (NYSE:BHVN) has observed the ...

Via Benzinga

75 Biggest Movers From Yesterday ↗

November 10, 2021

Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep. Check out these big penny stock gainers and losers...

Via Benzinga

58 Stocks Moving In Monday's Mid-Day Session ↗

November 09, 2021

Gainers Dover Motorsports, Inc. (NYSE: DVD) shares climbed 60.3% to $3.59 after Speedway Motorsports announced it will acquire the company for $3.61 per share in cash. TDH...

Via Benzinga

Pfizer Gains Outside US Rights To Biohaven's Migraine Treatment For $500M ↗

November 09, 2021

Biohaven Pharmaceutical Holding Company Ltd (NYSE: BHVN) and Pfizer Inc (NYSE: PFE) have announced an agreement for rimegepant in markets outside the U.S....

Via Benzinga

Why Biohaven Pharmaceuticals Stock Crumbled On This Premium Deal With Pfizer ↗

November 09, 2021

Biohaven will receive up to $1.24 billion in payments under a deal for Nurtec ODT.

Via Investor's Business Daily

Jim Cramer: MGM Resorts Has Good Top Management ↗

November 09, 2021

On CNBC’s "Mad Money Lightning Round," Jim Cramer said MGM Resorts International (NYSE: MGM) has a lot of good top management. With Wynn Resorts, Limited (NASDAQ...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

November 09, 2021

Gainers Compass Pathways (NASDAQ:CMPS) shares rose 18.43% to $51.0 during Tuesday's pre-market session. The company's market cap stands at $2.1 billion. As per the...

Via Benzinga

Cramer Likes American Eagle Outfitters And These 2 Pharma Stocks ↗

October 18, 2021

On CNBC’s “

Via Benzinga

Where Biohaven Pharma Hldgs Stands With Analysts ↗

October 06, 2021

Analysts have provided the following ratings for Biohaven Pharma Hldgs (NYSE:BHV...

Via Benzinga

10 Biggest Price Target Changes For Wednesday ↗

October 06, 2021

Goldman Sachs lowered the price target on Nucor Corporation (NYSE:

Via Benzinga

The Daily Biotech Pulse: Double Dose Of Positive Tidings For Merck, Alkermes Slips On Partial Termination Of J&J Licensing Deal, Amgen Migraine Drug Data ↗

November 09, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Merck Gets Antitrust Nod For Acceleron Deal In Germany, Austria, Announces...

Via Benzinga

What 7 Analyst Ratings Have To Say About Biohaven Pharma Hldgs ↗

October 05, 2021

Biohaven Pharma Hldgs (NYSE:BHVN) has observed the following analyst ratings...

Via Benzinga

The Week Ahead In Biotech (Nov. 7-Nov. 13): Earnings Taper Off, Multiple Conference Presentations, IPOs And More ↗

November 08, 2021

Biotech stocks reversed course and closed the week ended Nov. 5 lower, squandering the gains notched early in the week. What was good news for Pfizer, Inc. (NYSE: PFE) turned out...

Via Benzinga

Biohaven Surges To Record High As Kardashian-Backed Migraine Drug Outperforms — Again ↗

October 05, 2021

This company sells a migraine medicine backed by Khloe Kardashian.

Via Investor's Business Daily

The Daily Biotech Pulse: Takeda Suspends Studies On Safety Scare, Acer's Sleep Disorder Drug Filing Accepted For Review, Voyager's Licensing Options Deal ↗

October 06, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 5) Bicycle Therapeutics plc (...

Via Benzinga

The Daily Biotech Pulse: Merck Rallies On Antiviral Pill Data, Gilead Files For Yescarta Label Expansion, Exscientia IPO ↗

October 01, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Click here for accessing Benzinga's FDA Calendar Scaling The Peaks (Biotech Stocks...

Via Benzinga

Why Are Biohaven Shares Trading Lower On Monday? ↗

September 27, 2021

Biohaven Pharmaceutical Holding Company Ltd (NYSE: BHVN) has announced results from a focused analysis of verdiperstat trial in verdiperstat in multiple system...

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

September 27, 2021

Gainers Syndax Pharmaceuticals (NASDAQ:SNDX) shares moved upwards by 8.94% to $20.48 during Monday's pre-market session. The company's market cap stands at $995.9...

Via Benzinga

Cramer Gives His Opinion On Service Corporation, Vertex And More ↗

September 10, 2021

On CNBC's "Mad Money Lightning Round," Jim Cramer said he isn't happy with the way Inseego Corp (NASDAQ: INSG) acts. He is beginning to believe it deserves to...

Via Benzinga

The Daily Biotech Pulse: Cellect Jumps On First Apograft Transplantation, AstraZeneca, European Commission Bury Legal Hatchet, Cassava Defends Itself ↗

September 03, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 2) Abbott Laboratories (NYSE:...

Via Benzinga

The Daily Biotech Pulse: Assembly Bio Halts HBV Study, Moderna Initiates Submission For COVID-19 Booster Dose, FDA Nod For BeiGene, Tiziana Out-Licenses Foralumab ↗

September 02, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 1) AbbVie Inc. (NASDAQ: ABBV...

Via Benzinga

< Previous 1 2

...

9 10 11 12 13 14 15 16 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.